Front-line
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) (NCT00628238) | Chronic Lymphocytic Leukemia Research Consortium | 2008-02-01 |
Track Front-line automatically
Every clearance here is in the API, with alerts when new ones post.